Tag: pharmaceuticals
-
Patent Issued for Crispr-Edited Viruses in Microbiome
A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments.
-
Start-Up Developing Efficient RNA Process, Raises $12M
A company formed earlier this year is commercializing a more efficient process for making synthetic RNA molecules and raising $12 million in seed funds.
-
Company Formed to Boost Clinical Trial Success Odds
A pharma/tech industry group is starting a new company to use algorithms for finding gaps in preclinical data that can impair clinical trial progress.
-
Start-Up Licenses Gene-Edited Drug Discovery Tech.
A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases.
-
Trial Underway Assessing Gut Microbiome-Cancer Links
A clinical trial began collecting stool and blood samples to find connections between microbial communities in the gut and four types of solid-tumor cancer.
-
ALS Treatment Shown Safe, Affects Key Proteins
Results of a clinical trial show a combination of two approved drugs changes levels of proteins associated with ALS, with patients experiencing few adverse effects.
-
Addiction Biotech Using Crowdfunding for Investments
A start-up enterprise developing treatments for drug and alcohol addiction is raising investment capital with a direct pitch to small investors through a crowdfunding platform.
-
Eye Disease Gene-Therapy Biotech Adds Venture Funds
A biotechnology company designing treatments for inherited eye diseases with Crispr gene editing is raising €75 million in venture financing.
-
Cell, mRNA Therapy Biotech Raises $165M in Early Funds
A new company, founded by university medical researchers, is developing cell therapies engineered with messenger RNA or mRNA to work inside the body.
-
Trial Shows LSD Treatment Reduces Anxiety Symptoms
A clinical trial shows a medication made with lysergic acid diethylamide or LSD, given in a supervised clinical setting, helps reduce anxiety and depression symptoms.